These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30748020)

  • 61. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation.
    Park CH; Kim JH; Lee EB; Hur W; Kwon OJ; Park HJ; Yoon SK
    PLoS One; 2017; 12(1):e0169685. PubMed ID: 28081181
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
    Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
    World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.
    Liang N; Damdimopoulos A; Goñi S; Huang Z; Vedin LL; Jakobsson T; Giudici M; Ahmed O; Pedrelli M; Barilla S; Alzaid F; Mendoza A; Schröder T; Kuiper R; Parini P; Hollenberg A; Lefebvre P; Francque S; Van Gaal L; Staels B; Venteclef N; Treuter E; Fan R
    Nat Commun; 2019 Apr; 10(1):1684. PubMed ID: 30975991
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
    Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
    Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-3666 inhibits development of hepatic steatosis by negatively regulating PPARγ.
    Mittal S; Inamdar S; Acharya J; Pekhale K; Kalamkar S; Boppana R; Ghaskadbi S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158777. PubMed ID: 32755726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).
    Bartolini D; Torquato P; Barola C; Russo A; Rychlicki C; Giusepponi D; Bellezza G; Sidoni A; Galarini R; Svegliati-Baroni G; Galli F
    J Nutr Biochem; 2017 Sep; 47():120-131. PubMed ID: 28628909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
    Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress.
    Ji Y; Gao Y; Chen H; Yin Y; Zhang W
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Millet Bran Protein Hydrolysate Displays the Anti-non-alcoholic Fatty Liver Disease Effect via Activating Peroxisome Proliferator-Activated Receptor γ to Restrain Fatty Acid Uptake.
    Shan S; Zhou J; Yin R; Zhang L; Shi J; Qiao Q; Li Z
    J Agric Food Chem; 2023 Jan; 71(3):1628-1642. PubMed ID: 36638159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxicity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway.
    Liu E; Wang X; Li X; Tian P; Xu H; Li Z; Wang L
    Aging (Albany NY); 2020 Jul; 12(14):14189-14204. PubMed ID: 32680977
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
    Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
    Zhang Y; Wu B; Zhang H; Ge X; Ying S; Hu M; Li W; Huang Y; Wang L; Chen C; Shan X; Liang G
    J Cell Mol Med; 2018 Feb; 22(2):936-947. PubMed ID: 29077272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiolipin Synthase 1 Ameliorates NASH Through Activating Transcription Factor 3 Transcriptional Inactivation.
    Tu C; Xiong H; Hu Y; Wang W; Mei G; Wang H; Li Y; Zhou Z; Meng F; Zhang P; Mei Z
    Hepatology; 2020 Dec; 72(6):1949-1967. PubMed ID: 32096565
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species.
    Wang C; Zeng W; Wang L; Xiong X; Chen S; Huang Q; Zeng G; Huang Q
    Drug Dev Res; 2024 Jun; 85(4):e22213. PubMed ID: 38798186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.